VCA
CSLT

VIEX Capital Advisors’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

VIEX Capital Advisors’s Portfolio CSLT Stock Details CSLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-120,901
Closed -$170K – 21
2019
Q3 		$170K Buy
+120,901
New +$241K 0.1% 19

Other funds holding CSLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VIEX Capital Advisors's CSLT Position: Q4 2019 in Review

VIEX Capital Advisors sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q4 2019, closing a stake of 120,901 shares — an estimated $170K sold.

VIEX Capital Advisors first reported a position in CSLT in Q3 2019 and held it in 1 quarter. The position peaked at $170K in Q3 2019. 96 funds tracked by Wall St. Rank hold CSLT as of Q4 2019.

  • VIEX Capital Advisors reported no remaining CASTLIGHT HEALTH, INC. position as of Q4 2019 after selling out during the quarter.
  • VIEX Capital Advisors sold 120,901 CASTLIGHT HEALTH, INC. shares in Q4 2019, an estimated $170K.
  • VIEX Capital Advisors first reported a position in CASTLIGHT HEALTH, INC. in Q3 2019 and held it in 1 quarter.
  • VIEX Capital Advisors's CASTLIGHT HEALTH, INC. position peaked at $170K in Q3 2019.
  • 96 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q4 2019.

Based on VIEX Capital Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.